VolitionRx In Brief This Week: Co-Diagnostics, Oxford Nanopore, Prenetics, Dante Labs, Seegene, More News items for the week of May 8, 2022. VolitionRx Signs on Sage Healthcare as Distributor for Canine Cancer Test in Asia The Nu.Q Vet Cancer Test is an ELISA-based blood test that identifies and measures circulating nucleosomes, an early cancer marker. In Brief This Week: Biocept, SeqLL, Castle Biosciences, VolitionRx, More News items for the week of March 28, 2022. VolitionRx Awarded Additional $4 Million in Funding The company said that part of the funding was an unsecured loan to support the analysis of tumor DNA using a nucleosome immunoprecipitation method. VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays The companies said Tuesday that they are pursuing a clinical trial utilizing their respective liquid biopsy assays on clinical samples from lung cancer patients. Jul 2, 2018 VolitionRx Receives $700K in Funding From Regional Government May 9, 2018 VolitionRx, Active Motif Sign Global Sales, Distribution Agreement Jan 3, 2017 VolitionRx Gets CE Mark for Colorectal Cancer Screening Test Jun 3, 2016 VolitionRx Readying Launch of First Cancer Test Panel Using Circulating Nucelosome Technology Premium May 12, 2016 VolitionRx Launches Clinical Trial in Germany for Pancreatic Cancer Blood Test Apr 7, 2016 VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays Sep 22, 2015 VolitionRx Receives CE Mark for Colorectal Cancer Diagnosis Assay Mar 5, 2015 VolitionRx, ImmuneHealth Collaborate on Prostate Cancer Study Feb 24, 2015 VolitionRx Acquires Nucleosome Analysis IP from Chroma Therapeutics Feb 12, 2015 VolitionRx Closes Public Offering, Raises $8.5M Feb 6, 2015 VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share Breaking News Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.